A carregar...
Tracking down response and resistance to TRK inhibitors
Two recent studies validate the LMNA-NTRK1 fusion as an oncogenic driver and therapeutic target of TRK inhibitors. The LMNA-NTRK1 fusion occurs at low frequency across multiple tumor types. The studies highlight the increasing need to develop molecular biomarker-based clinical trials across cancer s...
Na minha lista:
| Publicado no: | Cancer Discov |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4709026/ https://ncbi.nlm.nih.gov/pubmed/26747892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-15-1352 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|